AIRLINK 75.25 Decreased By ▼ -0.18 (-0.24%)
BOP 5.11 Increased By ▲ 0.04 (0.79%)
CNERGY 4.60 Decreased By ▼ -0.15 (-3.16%)
DFML 32.53 Increased By ▲ 2.43 (8.07%)
DGKC 90.35 Decreased By ▼ -0.13 (-0.14%)
FCCL 22.98 Increased By ▲ 0.08 (0.35%)
FFBL 33.57 Increased By ▲ 0.62 (1.88%)
FFL 10.04 Decreased By ▼ -0.01 (-0.1%)
GGL 11.05 Decreased By ▼ -0.29 (-2.56%)
HBL 114.90 Increased By ▲ 1.41 (1.24%)
HUBC 137.34 Increased By ▲ 0.83 (0.61%)
HUMNL 9.53 Decreased By ▼ -0.37 (-3.74%)
KEL 4.66 No Change ▼ 0.00 (0%)
KOSM 4.70 Increased By ▲ 0.01 (0.21%)
MLCF 40.54 Decreased By ▼ -0.56 (-1.36%)
OGDC 139.75 Increased By ▲ 4.95 (3.67%)
PAEL 27.65 Increased By ▲ 0.04 (0.14%)
PIAA 24.40 Decreased By ▼ -1.07 (-4.2%)
PIBTL 6.92 No Change ▼ 0.00 (0%)
PPL 125.30 Increased By ▲ 0.85 (0.68%)
PRL 27.55 Increased By ▲ 0.15 (0.55%)
PTC 14.15 Decreased By ▼ -0.35 (-2.41%)
SEARL 61.85 Increased By ▲ 1.65 (2.74%)
SNGP 72.98 Increased By ▲ 2.43 (3.44%)
SSGC 10.59 Increased By ▲ 0.03 (0.28%)
TELE 8.78 Decreased By ▼ -0.11 (-1.24%)
TPLP 11.73 Decreased By ▼ -0.05 (-0.42%)
TRG 66.60 Decreased By ▼ -1.06 (-1.57%)
UNITY 25.15 Decreased By ▼ -0.02 (-0.08%)
WTL 1.44 Decreased By ▼ -0.04 (-2.7%)
BR100 7,806 Increased By 81.8 (1.06%)
BR30 25,828 Increased By 227.1 (0.89%)
KSE100 74,531 Increased By 732.1 (0.99%)
KSE30 23,954 Increased By 330.7 (1.4%)

bayerFRANKFURT: Leaving the euro zone could help Greece to recover economically and prevent the region's debt crisis from spreading, the head of German drugmaker Bayer was quoted as saying in a newspaper interview on Saturday.

 

The comments from Bayer CEO Marijn Dekkers add to a growing chorus of influential Germans speculating about the possible exit of Greece from the euro zone, despite Chancellor Angela Merkel's request for compatriots to tone down their rhetoric.

 

"Greece's exit from the euro may be better for all parties involved," Dekkers said, according to the Rheinische Post.

 

With its own currency, Greece might stand a better chance of escaping its economic slump, while keeping the euro strong would prevent a domino effect that could hit Spain and Portugal, Dekkers was quoted as saying.

 

He also said that if the drugs Bayer is developing are as successful as planned the company might become a top ten pharma company worldwide.

 

As a result, the company had no need to make a large takeover or merge with a competitor, he said.

 

Dekkers would neither sell nor seek to merge the Bayer Material Science unit with Lanxess or Evonik , he was quoted as saying.

 

Copyright Reuters, 2012

Comments

Comments are closed.